Zoledronic acid Treatment Report

Category: Prescription Drugs

Most Popular Types: Reclast, Zometa

false

What is Zoledronic acid?

An example of Zoledronic acid

Zoledronic acid is a bisphosphonate used in the treatment of hypercalcemia of malignancy (albumin-corrected serum calcium ≥12 mg/dL), multiple myeloma, bone metastases of solid tumors, Paget's disease of bone, postmenopausal osteoporosis.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
28 3 Efficacy_major Efficacy_cant_tell
5 1 Efficacy_cant_tell
2 1 Efficacy_cant_tell
1 0
1 0
1 0

See all 31 patients currently taking Zoledronic acid

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
1
Moderate
1
Mild
1
None
3

Commonly reported side effects, conditions, and hospitalizations associated with Zoledronic acid

1
1
1
1
1

Reported Dosages

Frequently reported dosages based on patients currently taking Zoledronic acid. See all 12 dosages

  1 mg yearly 1 intl units yearly 4 mg/5 mL yearly 5 mg/100 mL yearly 4 mg every 3 months 4 mg/5 mL every 3 months 4 mg every 6 weeks 4 mg monthly 4 mg/5 mL monthly 5 mg/100 mL weekly
  1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 20 Number of Patients: 20 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Zoledronic acid (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 3   Doctor's advice: 60%
Other 2   Other: 40%
Did not seem to work 1   Did not seem to work: 20%
Side effects too severe 1   Side effects too severe: 20%
Course of treatment ended 1   Course of treatment ended: 20%

See all 5 patients who’ve stopped taking Zoledronic acid

Currently Taking Zoledronic acid

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Zoledronic acid

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Zoledronic acid

Always
6 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Zoledronic acid

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
6 100%

Cost

Paid out of pocket

Cost of Zoledronic acid

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 50%
< $25
1 50%

Sort by: Helpfulness | Most Recent

2 patient evaluations for Zoledronic acid

Purpose: Osteoporosis (Started Apr 23, 2009)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jul 14, 2012 5 mg/100 mL Yearly Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
Jul 14, 2012
Advice & Tips
I WAS TOLD IT MADE A SIGNIFICANT IMPROVEMENT IN MY OSTEOPOROSIS.
  • Icon_thumb_off 0 helpful marks
Purpose: Other (Started Aug 22, 2008)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Sep 02, 2009 5 mg/100 mL Yearly Led_efficacy_1Led_defaultLed_defaultLed_defaultNone MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Dec 01, 2008 5 mg/100 mL Yearly ?Can't tell MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Side effects:
Bone Pain, Flu like symptoms
  • Icon_thumb_off 0 helpful marks

4 additional evaluations for Zoledronic acid are not currently shared publicly.

What is zoledronic acid?

Zoledronic acid (sometimes called zoledronate) is in a group of medicines called bisphosphonates (bis FOS fo nayts). Zoledronic acid inhibits the release of calcium from bones.

Zoledronic acid is used to treat Paget’s disease, and high blood levels of calcium caused by cancer (hypercalcemia of malignancy). Zoledronic acid also treats multiple myeloma (a type of bone marrow cancer) or bone cancer that has spread from elsewhere in the body.

Zoledronic acid is also used to treat osteoporosis in postmenopausal women, and to increase bone mass in men with osteoporosis. Zoledronic acid is used to treat or prevent osteoporosis in people who will be taking certain steroid medicines for 12 months or longer.

Zoledronic acid may also be used for other purposes not listed in this medication guide.


Precautions

You should not receive this medication if you are allergic to zoledronic acid or similar medicine such as alendronate (Fosamax), etidronate (Didronel), ibandronate (Boniva), pamidronate (Aredia), risedronate (Actonel), or tiludronate (Skelid).

You should also not receive zoledronic acid if you have:

  • low levels of calcium in your blood; or
  • if you are pregnant or breast-feeding.

Zometa and Reclast are two different brands of zoledronic acid. You should not be treated with Reclast if you are already receiving Zometa. Before receiving a Reclast injection, tell your doctor if you are already being treated with Zometa.

Before receiving zoledronic acid, tell your doctor if you have:

  • aspirin-sensitive asthma;
  • a thyroid or parathyroid disorder;
  • malabsorption syndrome (an inability to absorb food and nutrients properly);
  • a history of surgical removal of part of your intestine;
  • bone cancer; or
  • kidney disease.

Your doctor may recommend you have a dental exam for preventive tooth and gum care before you start your treatment with zoledronic acid. This is especially important if you have cancer, if you are undergoing chemotherapy or using steroids, or if you have poor dental health.

Some people using medicines similar to zoledronic acid have developed bone loss in the jaw, also called osteonecrosis of the jaw. Symptoms of this condition may include jaw pain, swelling, numbness, loose teeth, gum infection, or slow healing after injury or surgery involving the gums.

You may be more likely to develop osteonecrosis of the jaw if you have cancer or have been treated with chemotherapy, radiation, or steroids. Other conditions associated with osteonecrosis of the jaw include blood clotting disorders, anemia (low red blood cells), and dental surgery or pre-existing dental problems.

FDA pregnancy category D. This medication can cause harm to an unborn baby. Do not receive zoledronic acid without telling your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment.

Zoledronic acid can pass into breast milk and may harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

Avoid having any type of dental surgery while you are being treated with zoledronic acid. It may take longer than normal for you to recover.

Back to top

Instructions

Seek emergency medical attention if you think you have received too much of this medicine. Overdose symptoms may include numbness or tingling in your hands and feet, muscle stiffness, spasms in the muscles of your face, uneven heartbeats, and wheezing or trouble breathing.

Contact your doctor if you miss a dose of zoledronic acid.

Back to top

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these serious side effects:

  • urinating less than usual or not at all;
  • muscle spasms, numb or tingly feeling (especially around your mouth);
  • fever, chills, body aches, flu symptoms;
  • pale skin, easy bruising, unusual weakness;
  • severe joint, bone, or muscle pain; or
  • bronchospasm (wheezing, chest tightness, trouble breathing).

Less serious side effects may include:

  • cough;
  • loss of appetite, nausea, vomiting;
  • diarrhea, constipation;
  • headache, tired feeling;
  • mild joint or muscle pain; or
  • redness or swelling where the needle was placed.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Before receiving zoledronic acid, tell your doctor if you are using any of the following drugs:

  • a diuretic (water pill);
  • an antibiotic such as amikacin (Amikin), gentamicin (Garamycin), kanamycin (Kantrex), neomycin (Mycifradin, Neo-Fradin, Neo-Tab), netilmicin (Netromycin), streptomycin, tobramycin (Nebcin, Tobi);
  • other medicines that can harm your kidneys, such as pentamidine (Nebupent), tacrolimus (Prograf), amphotericin B (Fungizone, AmBisome, Amphotec, Abelcet), capreomycin (Capastat), rifampin (Rifadin, Rimactane, Rifater), vancomycin (Vancocin, Vancoled), acyclovir (Zovirax), adefovir (Hepsera), cidofovir (Vistide), or foscarnet (Foscavir);
  • cancer medicine such as aldesleukin (Proleukin), carmustine (BiCNU, Gliadel), cisplatin (Platinol), ifosfamide (Ifex), oxaliplatin (Eloxatin), plicamycin (Mithracin), streptozocin (Zanosar), thalidomide (Thalomid), or tretinoin (Vesanoid); or
  • a non-steroidal anti-inflammatory drug (NSAID) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), diclofenac (Cataflam, Voltaren), etodolac (Lodine), indomethacin (Indocin), ketoprofen (Orudis), piroxicam (Feldene), and others.

This list is not complete and there may be other drugs that can interact with zoledronic acid. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Aclasta, Reclast, Zometa, Zometa Concentrate, and zoledronic acid

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: